Alcon (NYSE:ALC) specializes in eye care products and services, offering a wide range of solutions for vision correction, eye health, and surgical procedures. It trades on the New York Stock Exchange under the ticker symbol (NYSE:ALC) and focuses on innovation to address some of the most common eye conditions and diseases. The company operates globally, running projects that aim to advance the field of ophthalmology through research and development of new products. Alcon's objective is to enhance people's vision and improve their quality of life through cutting-edge technologies and treatments for eye conditions, underscoring its commitment to eye care and vision health.